Active

MEDIFAR

Switched

BE0428055258

Rechtspersoon Private limited company 1 establishment

Noordkaai 9, 8870 Izegem Detailhandel in farmaceutische producten

Active for

40 year, 10 months

Financials

Financial year 2025

Gross margin

€ 176,068

▲ 18% vs 2024

Profit

Growing

€ 43,562

▲ 38% vs 2024

Debts

Low

€ 138,947

▼ 8% vs 2024

MEDIFAR from Izegem, company number BE0428055258, closed financial year 2025 with a result of € 43,562 after tax. For that financial year MEDIFAR recorded a gross margin of € 176,068 and equity of € 351,857. Compared with financial year 2024, the result moved from € 31,610 to € 43,562. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What happened at MEDIFAR?

What happened at MEDIFAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 43,562 (▲ 38% vs 2024). Source: NBB ↗
  • Alexo BV became a director. NBB
  • Sodiap BV became a director. NBB
  • New establishment in Mons. KBO
  • Start of the company according to the CBE. KBO

In short

From € 69,566 profit in 2021 to € 43,562 profit in 2025.

Paid € 79,281 in corporate taxes since 2021.

Best year ever: 2021, with € 69,566 profit.

On average € 176,100 of value added per employee in 2025.

A new publication or filing at MEDIFAR? We notify you, reason included.

Follow MEDIFAR

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind MEDIFAR are Sodiap BV and Alexo BV. The same people are also behind SDC, HC Pharma, APOTHEEK JENNE, Apotheek de Lisseweg and Apotheek Seurinck.

See the full network in the app

Directors

According to the 2025 annual accounts

Sodiap BV

Managing director · represented by Tom Goderis

Also active at: SDC, HC Pharma, APOTHEEK JENNE +29 more

since 2020

Alexo BV

Chairman of the board · represented by Olivier Delaere

Also active at: SDC, HC Pharma, SODIAP +39 more

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Noordkaai 9

8870 Izegem

2.206.769.596

Place de Cuesmes (C.) 7

7033 Mons

Active since 6 November 1985

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0428.055.258
VAT number
BE 0428.055.258
Registered office
Noordkaai 9, 8870 Izegem
Names & denominations
MEDIFAR
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
6 November 1985
Peppol
Active · Active since 6 Jun 2025
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Frequently asked questions

What is the enterprise number of MEDIFAR?
The enterprise number of MEDIFAR is BE0428055258.
What is the address of MEDIFAR?
The registered office of MEDIFAR is located at Noordkaai 9, 8870 Izegem.
When was MEDIFAR founded?
MEDIFAR was founded on 6 November 1985.
What is the main activity of MEDIFAR?
The main activity of MEDIFAR is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does MEDIFAR have a website?
No website is currently known for MEDIFAR.
How much profit did MEDIFAR make in 2025?
MEDIFAR posted a profit after taxes of € 43,562 in financial year 2025.
What is the revenue of MEDIFAR?
As a small company, MEDIFAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 176,068.
How many employees does MEDIFAR have?
According to the 2025 annual accounts, MEDIFAR has 1 full-time equivalents (FTE).
Where can I find the annual accounts of MEDIFAR?
MEDIFAR files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of MEDIFAR?
According to the 2025 annual accounts, the directors of MEDIFAR are: Sodiap BV, Alexo BV.
Who owns MEDIFAR?
Behind MEDIFAR are Sodiap BV and Alexo BV. The same people are also behind SDC, HC Pharma, APOTHEEK JENNE, Apotheek de Lisseweg and Apotheek Seurinck.